PubPat | GenomeWeb

PubPat

NEW YORK (GenomeWeb News) – Public interest groups Consumer Watchdog and the Public Patent Foundation said Tuesday that they have asked a federal appeals court to invalidate a patent held by the Wisconsin Alumni Research Foundation covering human embryonic stem cells.

WASHINGTON (GenomeWeb News) – US Supreme Court justices today heard arguments in favor of and against the patent eligibility of genes isolated from the body, a practice that the US Patent and Trademark Office has enabled for more than three decades.

NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation have asked the US Supreme Court to take up the question of gene patenting for a second time by looking again at the patentability of Myriad Genetics' claims on genes that predict risk of breast and ova

NEW YORK (GenomeWeb News) – In a case that could have wide implications for US gene patenting laws, a US Federal court today heard oral arguments focused on whether a recent Supreme Court decision that invalidated certain biotech patents will affect Myriad Genetics' patent claims related to breas

NEW YORK (GenomeWeb News) – The American Civil Liberties Union and the Public Patent Foundation said today that they have filed a brief with the US Court of Appeals for the Federal Circuit, or CAFC, in the ongoing case challenging Myri

This article has been updated to correct a typographical error.

By Turna Ray

By Turna Ray
The American Civil Liberties Union and the Public Patent Foundation have decided to ask the Supreme Court to take up their case challenging Myriad Genetics' patents on the BRCA 1 and BRCA 2 genes.

Pages

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.